ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 43.86 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2024-11-13
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2024-09-30 was 6.69K shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-12-31 was 0.00 shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-09-30 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month |
|---|---|---|---|---|
| 2024-09-30 | 6.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 43.86K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 37.17K shares 10-Q · filed 2024-08-09 | |||
| 2022-09-30 | 48.39K shares 10-Q/A · filed 2023-04-14 | |||
| 2020-12-31 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2021-11-15 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-15 | 9.55M shares 10-Q · filed 2021-11-15 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 9.55M shares 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | 9.55M shares 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | 9.55M shares 10-Q · filed 2021-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |